• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says
next post
J&J reaches sweeping talc deal that could end decade of litigation

related articles

Springsteen, other stars share stage with hardcore leftist...

October 5, 2026

Trump drops Republican Senator’s phone number in social...

October 5, 2026

Firebrand GOP rep: Democrats side with Iran ‘simply...

October 5, 2026

Tennessee prison chief resigns after failed execution as...

October 5, 2026

State’s largest mosque leader’s deportation fight takes dramatic...

October 1, 2026

Trump handing 1 million Americans Obamacare refund checks...

October 1, 2026

Iranian negotiators kicked out of US as talks...

October 1, 2026

10 Democrat-held House seats Republicans could flip to...

October 1, 2026

Trump’s new high-tech government hub holds some bizarre...

October 1, 2026

FAA breaks controller hiring record after chief warned...

October 1, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Dow rises as Wall Street awaits SK Hynix debut, tracks Iran tensions

    July 10, 2026
  • Netflix needs a new growth story to halt its stock decline

    June 23, 2026
  • Socialist Claire Valdez faces calls for federal probe after Mexico ‘fight’ pledge

    September 18, 2026
  • New Jersey sues Amazon, alleging poor pay and conditions for drivers

    August 4, 2026
  • Why OpenAI’s Altman is headed to Samsung, and what’s at stake

    June 11, 2026

Popular Posts

  • 1

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 4

    Micron stock falls 4%, why this analyst sees 40% upside for the stock?

    September 28, 2026
  • 5

    Evening digest: US jobs cool, gold falls as Treasury yields rise

    October 2, 2026

Categories

  • Editor's Pick (711)
  • Investing (2,372)
  • Stock (90)

Latest Posts

  • Bloom Energy stock forms island reversal amid Project Jupiter risks

    September 25, 2026
  • Asian tech stocks rally as SK Hynix vows $75B in shareholder returns after Q3 beat

    October 28, 2026
  • SanDisk stock keeps plunging, so why are analysts raising price targets?

    July 14, 2026

Recent Posts

  • Nasdaq opens higher as chip stocks rally, oil prices fall ahead of Fed decision

    October 27, 2026
  • Nike stock sinks after earnings as its comeback plan turns into more layoffs

    October 2, 2026
  • Thomas, Gorsuch target landmark ruling Trump says protects the ‘fake news’

    June 29, 2026

Editor’s Pick

  • OpenAI’s revenue run rate nears $70B as enterprise sales double

    September 29, 2026
  • Column: was SpaceX IPO the peak of the AI bull market?

    June 26, 2026
  • OpenAI commits to compliance with Trump’s AI review order

    June 5, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock